Scancell is developing therapeutic vaccines for the treatment of cancer and infectious diseases based on its ImmunoBody® and Moditope™ technology platforms. Scancell’s first cancer vaccine SCIB1 is being developed for the treatment of melanoma and is in Phase 1/2 clinical trials. Preliminary evidence from Part 1 of the study showing that SCIB1 produced an immune response which might be associated with clinical benefit in patients with malignant melanoma was released in December 2012.

Quadralogic Technologies, Inc. is a Canadian private company located in Vancouver, BC, that manufactures pharmaceutical and herbicide products.

ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan.

Part of Miltenyi GmbH, Miltenyi Biotec BV & Co. KG is a company headquartered in Bergisch Gladbach, Germany, that manufactures pharmaceutical products.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.

Miltenyi Biotec, Inc. provides equipment and related services for biomedical research. The company was founded on April 2, 1992 and is headquartered in Auburn, CA.

Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Oxford University Innovation is the University of Oxford's technology transfer company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Oxford University Innovation also manages Oxford University Consulting, which arranges consulting services providing clients access to the expertise of the University's academics. Oxford University’s overarching Strategic Plan begins, “The University of Oxford aims to lead the world in research and education” immediately followed by, “They seek to do this in ways which benefit society on a national and a global scale.” Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Their role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. They support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact. Income is shared with those involved according to the University’s Regulations.

Guizhou Tairuishengnuo Biopharmaceutical Co., Ltd., established on 2011-05-30, Business scope includes legal,regulations,Those prohibited by the State Council's decision shall not operate;law,regulations,The State Council has decided to allow(approval)of,After approval by the examination and approval authority(approval)file management;law,regulations,The State Council has decided that a license is not required(approval)of,Market entities independently choose to operate.(engaged in biomedicine,medical device,food research,to develop,Production,processing,Transfer and technical consulting services;Distribution of biochemicals(Except for special items),Instrumentation,food;Biomedical project investment;Biochemicals,Analysis of biological intermediates,Testing and technical consulting services;Medical Consulting and Medical Services(Operating with a valid license);Conference and exhibition services;Space lease,Equipment Leasing.(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department))

Qingdao Huazhicao Pharmaceutical Technology Co., Ltd., established on 2015-09-06, Business scope includes medical technology development,technical consulting,Technology Promotion,Technical Services;Operating other general business items that can be operated without administrative approval.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Amerimmune LLC is an American private company located in McLean, VA, that operates as a medical and diagnostics laboratory. The firm was founded by Oral Alpan, who is currently the CEO of the company.\nThe company says this about itself: Amerimmune LLC is a research center and immunology laboratory with a strong focus on identifying underlying mechanisms of immune disorders. Amerimmune’s mission is to bring relevant science, data, and diagnostic and therapeutic solutions to diseases that involve the immune system. Amerimmune LLC is a spinoff of Amerimmune Diagnostics LLC, which is focused on establishing a network of physician-owned immunology labs across the United States. Amerimmune Diagnostics’ clinical approach led to the development of the innovative therapeutics’ technology upon which Amerimmune was founded. When the COVID-19 pandemic emerged, Amerimmune brought its expertise to bear against this devastating disease. Amerimmune is a privately held development-stage company based in Fairfax, VA.

The Istituto Superiore di Sanità (Italian National Institute of Health), also ISS, is an Italian public institution that, as the leading technical-scientific body of the Italian National Health Service (Servizio Sanitario Nazionale), performs research, trials, control, counseling, documentation and training for public health. The Institute is under the supervision of the Ministero della Salute (Ministry of Health).

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

QLT PhotoTherapeutics, Inc., a subsidiary of Novelion Therapeutics, Inc., is a company headquartered in Vancouver, BC, Canada. The firm manufactures and develops drugs.

Norwood Immunology Pty Ltd. develops and commercializes immunology-related technologies for medical technology. The company was founded in December 2000 and is headquartered in Melbourne, Australia.

Immunex Corporation develops, manufactures, and markets therapeutic products for the treatment of cancer, infectious diseases, and autoimmune disorders. It offers products, such as Enbrel that is used in the treatment of rheumatoid arthritis; Novantrone, which is used to treat acute nonlymphocytic leukemia and pain associated with prostate cancer; and Leukine for use in bone marrow transplant patients. The company has franchise operations. It has a strategic alliance with American Home Products. The company was founded in 1981 and is based in Seattle, Washington. As of July 15, 2002, Immunex Corporation was acquired by Amgen, Inc.

Shanghai New Changan Biotechnology Co., Ltd., established on 2018-02-28, The scope of business includes engaging in technology development in the professional field of biotechnology,technology transfer,technical consulting,Technical Services. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]